Diabetes News-Stream

Aggregierte Informationen zum Diabetes, Insulin und Diabetes mellitus für Diabetiker.

  • Startseite
  • News
  • Über
  • Datenschutz
    • Datenauszug
    • Löschanfrage
  • Impressum
    • Kontakt

22. Februar 2023 19:47

Fasten bei Diabetes – geht das?

Ob zur Gewichtsreduktion oder um den Körper zu „reinigen“: Fasten, also der bewusste Verzicht auf Nahrung, ist gerade in den ersten Monaten des Jahres für viele Menschen ein Thema. Funktioniert das

17. Februar 2023 2:00

Gastrointestinal Consequences of Type 2 Diabetes Mellitus and Impaired Glycemic Homeostasis: A Mendelian Randomization Study

OBJECTIVEWe conducted a Mendelian randomization (MR) study to examine the associations of type 2 diabetes and glycemic traits with gastrointestinal diseases (GDs).RESEARCH DESIGN AND

17. Februar 2023 2:00

Initiation of Continuous Glucose Monitoring Is Linked to Improved Glycemic Control and Fewer Clinical Events in Type 1 and Type 2 Diabetes in the Veterans Health Administration

OBJECTIVETo determine the benefit of starting continuous glucose monitoring (CGM) in adult-onset type 1 diabetes (T1D) and type 2 diabetes (T2D) with regard to longer-term glucose control and serious

15. Februar 2023 2:00

No Substitute for Hard Work: Dedication to the Diabetes Community

Editor’s NoteThis article is adapted from a speech Dr. Kirksey delivered in June 2022 as President, Health Care & Education of the American Diabetes Association. He delivered his address at the

14. Februar 2023 2:00

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy

OBJECTIVEAutomated insulin delivery (AID) has rarely been studied in adults with type 2 diabetes. We tested the feasibility of using AID for type 2 diabetes with the Omnipod 5 System in a multicenter

8. Februar 2023 12:56

Special Edition: The 2023 Standards of Care – CV Risk Reduction – February 2023

In this special podcast we will focus on the changes in recommendations for CV Risk Reduction published in the 2023 American Diabetes Association’s Standards of Care. The report is available at:  

7. Februar 2023 2:00

Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI)

OBJECTIVEMaintenance of glycemic control during and after exercise remains a major challenge for individuals with type 1 diabetes. Glycemic responses to exercise may differ by exercise type (aerobic,

1. Februar 2023 19:48

Accu-Chek Instant oder Accu-Chek Guide kostenfrei testen

Euer Blutzuckermessgerät ist in die Jahre gekommen, nicht mehr auffindbar oder wird vom Hersteller nicht mehr vertrieben? Dann habt ihr jetzt die Gelegenheit, die Blutzuckermessgeräte Accu-Chek

1. Februar 2023 2:00

Insulin Deficiency From Insulin Gene Mutation Leads to Smaller Pancreas

OBJECTIVETo determine the mechanism of reduced pancreas size in type 1 diabetes and the significance of islet-derived insulin in pancreatic growth.RESEARCH DESIGN AND METHODSUsing a validated and

30. Januar 2023 2:00

Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation: A Randomized, Double-Blind, Crossover Study in People With Type 1 Diabetes

OBJECTIVETo evaluate the pharmacokinetics, pharmacodynamics, and safety of a novel U500 insulin aspart formulation (AT278 U500) compared with insulin aspart (IAsp U100).RESEARCH DESIGN AND METHODSThis

27. Januar 2023 19:47

183. Genehmigung nach dem Stammzellgesetz

Generierung von funktionalen pankreatischen Inselzellen aus hES-Zellen zur Erforschung von Ursachen und Entwicklung von Zellersatztherapien des Diabetes mellitus. .... mehr lesen: RKI -

26. Januar 2023 14:40

Diabetes and pre-diabetes care market size in India from FY 2016-2031

In financial year 2021, the market size of diabetes and pre-diabetes care market in India was valued at about 17 billion U.S. dollars. It is forecasted to reach about 34 billion dollars in 2026 and 59

«
»
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • XING

Copyright © 2023 Afra Schmidt · Website by Firstmover Pro ·Idee Thomas Schmidt

WP DSGVO Tools (GDPR) for Wordpress and WooCommerce Sofern Sie Ihre Datenschutzeinstellungen ändern möchten z.B. Erteilung von Einwilligungen, Widerruf bereits erteilter Einwilligungen klicken Sie auf nachfolgenden Button. Einstellungen